Briotech Presents Prion Research at the US FDA

By special request of the US Food and Drug Administration, Briotech is invited to present its research supporting prion inactivation with use of BrioHOCl™ at the FDA Silver Springs, MD location.

United States Food and Drug Administration
February 06, 2018

High Level Inactivation of Prions and Other Infectious Pathogens with Novel Preparations of (BrioHOCl™) Hypohalous Acids

2017

Global Infection Control Specialists Learn Briotech Breakthroughs

Stabilized hypochlorous acid (HOCl) is rapidly emerging as an exceptionally effective environmental disinfectant. This development seems especially fitting amidst growing concerns about eco-persist...

2018

BrioHOCl™ Presents at the 18th International Congress on Infectious Diseases

Briotech receives an invitation from the ISID to present BrioHOCl™ on an international stage for infectious diseases.